Governance Classic Home
Torrent Pharmaceuticals LtdPharmaceuticalsINE685A01028Consolidated₹4840.00-35.00 (-0.72%)Jun-26
Valuation
Market Cap₹1.84L Cr
TTM PE77.32x
Forward PE80.40x
PEG-37.35
Book Value₹220.55
P/B21.95x
TTM EPS₹62.60
Fwd EPS₹60.20
TTM Revenue₹15.72K Cr
TTM PAT₹2.16K Cr
TTM EBITDA₹5.19K Cr
TTM EBIT₹3.68K Cr
Last Qtr PAT₹566.00 Cr
Last Qtr EBITDA₹1.66K Cr
Last Qtr EBIT₹1.07K Cr
Profitability
ROE25.70%
ROCE14.95%
TTM NPM13.71%
TTM EBITDA %33.02%
Curr OPM11.53%
Last OPM8.71%
Curr NPM—
Last NPM—
Curr EPS₹14.87
Last EPS₹11.51
Balance sheet
Equity₹169.00 Cr
Reserve₹8.22K Cr
Total Debt₹15,030.00 Cr
D/E1.79x
Interest %53.89%
Curr Interest₹305.00 Cr
Price / range
Close₹4840.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-0.72%
1W-2.53%
1M-2.64%
3M+8.87%
6M+12.77%
1Y+35.69%
2Y+44.03%
3Y+156.81%
5Y+212.54%
Diwali+25.79%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue4,158+58.9%2,7352,5992,7622,61610,712
Other Income-2158-8-27-518
Total Income4,137+58.4%2,7932,5912,7352,61110,730
Interest293225343745341
Expenditure-3,453-84.8%-2,154-1,824-1,916-1,869-7,763
PBDT000000
EBITDA1,573+60.7%1,0031,0001,0729794,054
Depreciation-575-197-191-189-187-764
EBIT998+26.0%8068098837923,290
PBT663-10.6%5927578067422,897
Tax-171-125-180-209-191-705
Equity169.23169.23169.230169.23169.23
OPM16.0321.2029.2229.1828.4227.00
Net Profit492-10.7%4675775975512,192
NPM11.8916.7222.2721.6121.1020.43
EPS12.94-20.5%13.8017.0417.6416.2864.75

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue10,712+10.6%9,682+13.5%8,533+10.9%7,695+14.1%6,742+4.5%6,451
Other Income18329182204118
Total Income10,730+10.5%9,714+12.6%8,624+10.9%7,777+12.0%6,946+5.7%6,569
Expenditure-7,763-9.6%-7,080-5.6%-6,707-8.2%-6,200-13.1%-5,480-5.3%-5,203
Interest-341-213-303-298-236-339
PBDT000000
EBITDA4,054+13.4%3,575+23.7%2,890+17.2%2,465+17.4%2,100-4.4%2,197
Depreciation-764-760-761-672-602-610
EBIT3,290+16.9%2,815+32.2%2,129+18.7%1,793+19.7%1,498-5.6%1,587
PBT2,897+11.0%2,610+36.2%1,917+21.6%1,577+7.6%1,466+7.3%1,366
Tax-705-722-560-525-475-228
Equity169.23169.230000
OPM (%)27.0026.8722.0020.0021.0021.00
Net Profit2,192+16.1%1,888+39.1%1,357+29.0%1,052+6.2%991-12.9%1,138
NPM (%)20.4319.4416.0014.0014.0017.00
EPS (Rs)64.75+16.1%55.79+39.1%40.10+29.1%31.07-47.0%58.59-12.9%67.24
CEPS64.7555.7940.1031.0758.5967.24

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue4,921+54.8%4,1973,3033,3023,17813,980
Other Income-12-17-13-27-37-94
Total Income4,909+56.3%4,1803,2903,2753,14113,886
Interest305236454856385
Expenditure-4,155-72.9%-3,585-2,466-2,471-2,403-10,925
PBDT000000
EBITDA1,664+61.2%1,3561,0881,0831,0324,559
Depreciation-593-508-206-204-201-1,119
EBIT1,071+28.9%8488828798313,440
PBT733-0.7%5298147917382,872
Tax-167-165-179-200-190-734
Equity169.23169.2300169.23169.23
OPM14.9312.6624.7424.1523.5020.68
Net Profit566+3.3%3646355915482,138
NPM11.538.7119.3018.0517.4515.40
EPS14.87-8.2%11.5118.7717.4516.1963.92

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 21-22FY 20-21FY 19-20
Revenue13,980+21.4%11,516+7.3%10,7288,508+6.3%8,005+0.8%7,939
Other Income-94235819757122
Total Income13,886+20.3%11,539+7.0%10,7868,705+8.0%8,062+0.0%8,061
Expenditure-10,925-23.6%-8,842-3.8%-8,522-6,994-7.0%-6,536+4.9%-6,874
Interest-385-252-354-255-358-451
PBDT000000
EBITDA4,559+22.5%3,721+10.5%3,3682,431-2.2%2,485+14.5%2,170
Depreciation-1,119-795-808-662-658-654
EBIT3,440+17.6%2,926+14.3%2,5601,769-3.2%1,827+20.5%1,516
PBT2,872+7.4%2,673+13.6%2,3521,226-19.7%1,526+28.6%1,187
Tax-734-762-696-449-274-162
Equity169.23169.230000
OPM (%)20.6823.1621.8114.0818.9314.73
Net Profit2,138+11.9%1,911+15.4%1,656777-37.9%1,252+22.1%1,025
NPM (%)15.4016.5615.358.9315.5312.72
EPS (Rs)63.92+13.2%56.47+15.4%48.9445.93-37.9%73.98+22.2%60.55
CEPS63.9256.4748.9445.9373.9860.55

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

39
YearTypeAmountEx-Date
2026Final Dividend929 May 2026
2026Interim Dividend2918 Feb 2026
2025Final Dividend620 Jun 2025
2025Interim Dividend2631 Jan 2025
2024Final Dividend621 Jun 2024
2024Interim Dividend2212 Feb 2024
2023Final Dividend823 Jun 2023
2023Interim Dividend1403 Feb 2023
2022Final Dividend803 Jun 2022
2022Special Dividend1503 Jun 2022
2022Interim Dividend2502 Feb 2022
2021Final Dividend1517 Jun 2021
2021Interim Dividend2015 Feb 2021
2020Interim Dividend1718 Mar 2020
2020Special Dividend1518 Mar 2020
2019Final Dividend413 Jun 2019
2019Interim Dividend1306 Feb 2019
2018Final Dividend518 Jun 2018
2018Interim Dividend915 Feb 2018
2017Final Dividend419 Jun 2017
2017Interim Dividend1010 Feb 2017
2016Interim Dividend1516 Mar 2016
2016Interim Dividend2011 Feb 2016
2015Final Dividend6.2515 Jun 2015
2015Interim Dividend502 Feb 2015
2014Final Dividend516 Jun 2014
2014Interim Dividend524 Jan 2014
2013Final Dividend710 Jun 2013
2013Final Dividend710 Jun 2013
2013Special Dividend1010 Jun 2013
2013Special Dividend1010 Jun 2013
2013Interim Dividend601 Feb 2013
2012Final Dividend2.511 Jun 2012
2012Interim Dividend627 Jan 2012
2011Final Dividend606 Jun 2011
2011Special Dividend206 Jun 2011
2010Final Dividend604 Jun 2010
2009Final Dividend408 Jun 2009
2008Final Dividend3.519 Jun 2008

Bonus

2
YearRatioEx-Date
20221:108 Jul 2022
20131:123 Jul 2013

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers